At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

I share how hope, even when uncertain, helped me through cancer and honors its role in balancing realism, resilience and ...

Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.

Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...

An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and ...

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who ...

Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore ...